New hope for the toughest TB cases: 6-Month drug combo tested
NCT ID NCT02333799
Summary
This study tested a new combination of three drugs (bedaquiline, pretomanid, and linezolid) for people with severe, drug-resistant tuberculosis (TB) that other treatments couldn't cure. It involved 109 participants aged 14 and over and aimed to see if a shorter, 6-month treatment could effectively control the TB infection and prevent it from coming back. Researchers measured success by checking if the TB bacteria disappeared from participants' sputum and stayed gone after treatment ended.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King DinuZulu Hospital Complex
Sydenham, Durban, 4001, South Africa
-
Sizwe Tropical Disease Hospital
Sandringham, Johannesburg, 2131, South Africa
-
Task Applied Science - Brooklyn Chest Hospital
Ysterplaat, Cape Town, 7405, South Africa
Conditions
Explore the condition pages connected to this study.